AU2013902377A0 - A super-agonist monoclonal antibody to human IL-21 and its application in immunomodulation - Google Patents
A super-agonist monoclonal antibody to human IL-21 and its application in immunomodulationInfo
- Publication number
- AU2013902377A0 AU2013902377A0 AU2013902377A AU2013902377A AU2013902377A0 AU 2013902377 A0 AU2013902377 A0 AU 2013902377A0 AU 2013902377 A AU2013902377 A AU 2013902377A AU 2013902377 A AU2013902377 A AU 2013902377A AU 2013902377 A0 AU2013902377 A0 AU 2013902377A0
- Authority
- AU
- Australia
- Prior art keywords
- immunomodulation
- super
- human
- application
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002519 immonomodulatory Effects 0.000 title 1
- 102000005614 monoclonal antibodies Human genes 0.000 title 1
- 108010045030 monoclonal antibodies Proteins 0.000 title 1
- 230000002483 superagonistic Effects 0.000 title 1
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201480037182.8A CN105579470B (en) | 2013-06-27 | 2014-06-27 | IL-21 binding proteins and uses thereof |
ES14817437T ES2898650T3 (en) | 2013-06-27 | 2014-06-27 | IL-21 binding proteins and uses thereof |
US14/392,256 US10077301B2 (en) | 2013-06-27 | 2014-06-27 | IL-21 binding proteins |
AU2014302028A AU2014302028B2 (en) | 2013-06-27 | 2014-06-27 | IL-21 binding proteins and uses thereof |
EP14817437.8A EP3013858B1 (en) | 2013-06-27 | 2014-06-27 | Il-21 binding proteins and uses thereof |
JP2016522133A JP6563389B2 (en) | 2013-06-27 | 2014-06-27 | IL-21 binding protein and use thereof |
PCT/AU2014/000673 WO2014205501A1 (en) | 2013-06-27 | 2014-06-27 | Il-21 binding proteins and uses thereof |
CA2915882A CA2915882C (en) | 2013-06-27 | 2014-06-27 | Il-21 binding proteins and uses thereof |
US16/101,976 US10787510B2 (en) | 2013-06-27 | 2018-08-13 | Methods of treating cancer using an IL-21 agonist |
US16/937,121 US20210002362A1 (en) | 2013-06-27 | 2020-07-23 | Il-21 binding proteins and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2013902377A0 true AU2013902377A0 (en) | 2013-07-11 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL270218B (en) | Anti-activin a antibodies and uses thereof | |
EP3013365A4 (en) | Rm2 antigens and use thereof | |
IL240443A0 (en) | Highly galactosylated anti-tnf-alpha antibodies and uses thereof | |
ZA201407927B (en) | Anti-egfr antibodies and uses thereof | |
ZA201500887B (en) | Human anti-cd27 antibodies, methods and uses | |
EP3026062A4 (en) | Anti-pd-1 antibody and use thereof | |
EP3003248A4 (en) | Skin care sheet and skin care article | |
EP3019240A4 (en) | Anti-complement factor c1q antibodies and uses thereof | |
EP3003390A4 (en) | Anti-c10orf54 antibodies and uses thereof | |
EP2970490A4 (en) | Antibodies to mica and micb proteins | |
EP3071740A4 (en) | Soft and durable nonwoven composite | |
EP3079719B8 (en) | Anti-siglec-8 antibodies and methods of use thereof | |
EP3066470A4 (en) | Humanized anti-ceacam5 antibody and uses thereof | |
EP3001836A4 (en) | Design and use of specific regulatory t-cells to induce immune tolerance | |
EP2968503A4 (en) | Anti-hepcidin antibodies and uses thereof | |
EP3178847A4 (en) | Anti-tnf-alpha fully human monoclonal antibodies with low immunogenicity and application thereof | |
EP3047389A4 (en) | Using user mood and context to advise user | |
EP3060253A4 (en) | ANTI-Ly6E ANTIBODIES AND METHODS OF USE | |
EP3060724A4 (en) | Improvements in and relating to couplers | |
IL240440A0 (en) | Highly galactosylated anti-her2 antibodies and uses thereof | |
EP2951208A4 (en) | Anti-cd83 antibodies and use thereof | |
EP3010934A4 (en) | Antibodies to human resistin | |
EP2970454A4 (en) | Antibodies specific to a novel epitope on cemx of human membrane-bound ige and uses thereof in treating ige-mediated diseases | |
AU2013902377A0 (en) | A super-agonist monoclonal antibody to human IL-21 and its application in immunomodulation | |
AU2014203022A1 (en) | Improvements in and Relating to Packaging |